Inflammatory myofibroblastic tumor of the uterus with prominent myxoid change

被引:42
作者
Shintaku, Masayuki [1 ]
Fukushima, Akiko
机构
[1] Osaka Red Cross Hosp, Dept Pathol, Osaka 5438555, Japan
[2] Osaka Red Cross Hosp, Dept Gynecol & Obstet, Osaka 5438555, Japan
关键词
inflammatory myofibroblastic tumor; myxoid stroma; uterus;
D O I
10.1111/j.1440-1827.2006.02018.x
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
A surgical case of inflammatory myofibroblastic tumor arising in the uterine corpus and exhibiting prominent myxoid change of the stroma is reported. The patient was a 63-year-old woman with a large tumor mass that filled the uterine cavity and measured 11 cm in maximal dimension. The tumor had a gelatinous appearance and consisted of a loose proliferation of stellate or polygonal cells on a myxomatous background. Fascicular proliferation of spindle cells was also observed focally, and a chronic inflammatory cell infiltration was seen in many areas. Tumor cells had mild atypism and were immunoreactive for vimentin, alpha-smooth muscle actin, and anaplastic lymphoma kinase (ALK). Focal immunoreactivity for high-molecular-weight caldesmon (h-caldesmon) was also noted. The patient has been free from recurrence for 8 months. Inflammatory myofibroblastic tumor of the uterus occasionally shows prominent myxoid change of the stroma, and differentiation from myxoid leiomyosarcoma is problematic in these cases. Based on the immunoreactivity of tumor cells for ALK and h-caldesmon, the present tumor was considered inflammatory myofibroblastic tumor showing a focal phenotypic transition from myofibroblasts to smooth muscle cells.
引用
收藏
页码:625 / 628
页数:4
相关论文
共 18 条
[1]   Inflammatory myoblastic tumor of the uterus and interleukin-6 [J].
Azuno, Y ;
Yaga, K ;
Suehiro, Y ;
Ariyama, S ;
Oga, A .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 189 (03) :890-891
[2]   Is anti-h-caldesmon useful for distinguishing smooth muscle and myofibroblastic tumors? An immunohistochemical study [J].
Ceballos, KM ;
Nielsen, GP ;
Selig, MK ;
O'Connell, JX .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 114 (05) :746-753
[3]   Anaplastic lymphoma kinase expression in inflammatory pseudotumors [J].
Chan, JKC ;
Cheuk, W ;
Shimizu, M .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (06) :761-768
[4]   ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor [J].
Coffin, CM ;
Patel, A ;
Perkins, S ;
Elenitoba-Johnson, KSJ ;
Perlman, E ;
Griffin, CA .
MODERN PATHOLOGY, 2001, 14 (06) :569-576
[5]   EXTRAPULMONARY INFLAMMATORY MYOFIBROBLASTIC TUMOR (INFLAMMATORY PSEUDOTUMOR) - A CLINICOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL STUDY OF 84 CASES [J].
COFFIN, CM ;
WATTERSON, J ;
PRIEST, JR ;
DEHNER, LP .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1995, 19 (08) :859-872
[6]   Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor - A comparative immunohistochemical study [J].
Cook, JR ;
Dehner, LP ;
Collins, MH ;
Ma, ZG ;
Morris, SW ;
Coffin, CM ;
Hill, DA .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (11) :1364-1371
[7]   Myofibrosarcoma [J].
Fisher, C .
VIRCHOWS ARCHIV, 2004, 445 (03) :215-223
[8]   INFLAMMATORY PSEUDOTUMOR OF THE UTERUS [J].
GILKS, CB ;
TAYLOR, GP ;
CLEMENT, PB .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1987, 6 (03) :275-286
[9]  
Griffin CA, 1999, CANCER RES, V59, P2776
[10]  
Hussong JW, 1999, MODERN PATHOL, V12, P279